Bio-Works Technologies AB

Equities

BIOWKS

SE0007387089

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm 11:17:58 2024-04-26 am EDT 5-day change 1st Jan Change
2.94 SEK -2.00% Intraday chart for Bio-Works Technologies AB -22.63% -58.59%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Bio-Works Technologies AB Announces Johan Sedihn Declines Re-Election as Member of Board CI
Bio-Works Technologies AB Confirms New Order from Indian Biotherapeutic Manufacturer Worth SEK 3.1 Million CI
Bio-Works Technologies AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Bio-Works Expands Product Range with Introduction of WorkBeads 40 Butyl SH CI
Bio-Works Technologies Books SEK1.9 Million Workbeads Resin Order MT
Bio-Works Receives Repeat Order for Workbeads Resin CI
Bio-Works Technologies AB's Nomination Committee for the 2024 Annual General Meeting CI
Bio-Works Technologies Books Order from American Gene Therapy Products Manufacturer MT
Bio-Works Secures SEK 0.8 Million Order for Gene Therapy Manufacturing CI
Bio-Works Technologies AB Reports Sales Results for the Third Quarter of 2023 CI
Sweden's Bio-Works Technologies Names CFO MT
Bio-Works Technologies AB Announces Appointment of Arne Hauge as Chief Financial Officer CI
Bio-Works Technologies AB Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Bio-Works Technologies to Reduce Workforce Under Restructuring Program; Shares Down 10% MT
Bio-Works Implements Restructuring Program CI
Patrick Van De Velde Declines Re-Election as Director At Bio-Works Technologies CI
Bio-Works Technologies AB Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Sweden's Bio-Works Technologies Books SEK3.4 Million GoBio Order MT
Bio-Works Confirms New Order for Gobio Prepacked Columns to the American Market CI
Bio-Works Technologies Enters Finnish Distribution Deal With Biotop MT
Bio-Works Signs Distributor Agreement with Biotop Oy for the Finnish Market CI
Bio-Works Technologies AB Wins EU Grant for Development of Environmentally-Friendly Purification of Biotherapeutics CI
Bio-Works Technologies AB Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Bio-Works Technologies AB Launches GoBio, New Product Line Saves Time in Biotherapeutic Production CI
Bio-Works Technologies AB Reports Sales Results for the First Quarter of 2022 CI
Chart Bio-Works Technologies AB
More charts
Bio-Works Technologies AB is a Sweden-based biotechnology company. The Company designs, develops, manufactures and supplies products for purification and separation of proteins and other molecules for application in areas such as Research and Laboratory, Life Science and Biopharma, as well as Food and Beverage. The Company uses technology based on uses Agarose beads, which are derived from seaweed in the process of liquid chromatography and serve as adsorbers that bind molecules of interest allowing them to be recovered. Its product offerings, marketed under brand names WorkBeads, BabyBio and OptioBio, include Activated Resin for coupling ligands, BabyBio Columns for rapid protein purification and condition screening, Immobilized Metal-ion Affinity Chromatography (IMAC) Resin, Ion Exchange Chromatography (IEX) Resin and OptioBio Glass Columns for small-scale purification and screening, among others.
More about the company

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. BIOWKS Stock
  4. News Bio-Works Technologies AB
  5. Bio Works Technologies : Works Enters Partnership for Gene Therapy Vectors